Geneos Wealth Management Inc. - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 246 filers reported holding EDITAS MEDICINE INC in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
Geneos Wealth Management Inc. ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q3 2023$3,120
-5.2%
4000.0%0.00%
Q2 2023$3,292
+13.5%
4000.0%0.00%
Q1 2023$2,900
-18.3%
4000.0%0.00%
Q4 2022$3,548
-11.3%
4000.0%0.00%
Q3 2022$4,000
-33.3%
400
-20.0%
0.00%
Q2 2022$6,000
-33.3%
500
-1.2%
0.00%
Q1 2022$9,000
-65.4%
506
-49.8%
0.00%
-100.0%
Q4 2021$26,000
-35.0%
1,0070.0%0.00%
-50.0%
Q3 2021$40,000
-27.3%
1,0070.0%0.00%0.0%
Q2 2021$55,000
+48.6%
1,0070.0%0.00%
+100.0%
Q1 2021$37,000
-17.8%
1,007
-9.0%
0.00%
-50.0%
Q4 2020$45,000
+18.4%
1,107
-14.6%
0.00%0.0%
Q3 2020$38,000
+22.6%
1,297
+18.2%
0.00%0.0%
Q2 2020$31,000
+210.0%
1,097
+116.4%
0.00%
+100.0%
Q1 2020$10,000
-9.1%
5070.0%0.00%0.0%
Q3 2019$11,000
-8.3%
5070.0%0.00%0.0%
Q2 2019$12,0000.0%5070.0%0.00%0.0%
Q1 2019$12,000
-14.3%
507
-28.3%
0.00%0.0%
Q4 2018$14,000
-54.8%
707
-29.3%
0.00%
-50.0%
Q3 2018$31,000
-34.0%
1,000
-24.5%
0.00%
-50.0%
Q2 2018$47,000
+9.3%
1,3250.0%0.00%0.0%
Q1 2018$43,000
-6.5%
1,325
-13.1%
0.00%0.0%
Q4 2017$46,0001,5250.00%
Other shareholders
EDITAS MEDICINE INC shareholders Q4 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 1,674,435$51,455,00013.05%
TRV GP III, LLC 906,176$27,847,0009.75%
ARK Investment Management 1,112,845$34,198,0002.72%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,709,400$52,530,0002.07%
Casdin Capital, LLC 133,333$4,097,0001.00%
Global Thematic Partners, LLC 614,052$18,869,0000.62%
MORGENS WATERFALL VINTIADIS & CO INC 20,000$615,0000.48%
Ghost Tree Capital, LLC 65,000$1,997,0000.47%
ACUTA CAPITAL PARTNERS, LLC 64,000$1,967,0000.37%
VIKING GLOBAL INVESTORS LP 1,709,401$52,530,0000.32%
View complete list of EDITAS MEDICINE INC shareholders